CN109336905A - The synthetic method of Cefazolin Intermediate TDA - Google Patents
The synthetic method of Cefazolin Intermediate TDA Download PDFInfo
- Publication number
- CN109336905A CN109336905A CN201811581537.6A CN201811581537A CN109336905A CN 109336905 A CN109336905 A CN 109336905A CN 201811581537 A CN201811581537 A CN 201811581537A CN 109336905 A CN109336905 A CN 109336905A
- Authority
- CN
- China
- Prior art keywords
- tda
- cefazolin
- synthetic method
- aca
- phosphate buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Abstract
The present invention relates to medical synthesis technical fields, and in particular to a kind of synthetic method of Cefazolin Intermediate TDA.The synthetic method of the Cefazolin Intermediate TDA is, using phosphate buffer and acetone as solvent, using 7-ACA and thiadiazoles as raw material, reacts under catalyst of triethylamine or ammonium hydroxide effect, obtains TDA.Synthetic method of the invention makees solvent by using phosphate buffer, to maintain the stabilization of reacting liquid pH value, it solves the problems, such as to add lye repeatedly because pH is reduced in reaction process, simple process, solvent are mild, reduce the use of organic solvent, the high income of the TDA of synthesis, purity is high, color are good.
Description
Technical field
The present invention relates to medical synthesis technical fields, and in particular to a kind of synthetic method of Cefazolin Intermediate TDA.
Background technique
Cefazolin sodium belongs to first generation cephalosporin class antibiotic, because its is cheap and therapeutic effect is good, in clinic
On have a wide range of applications.TDA is the important intermediate for producing Cefazolin, and 7-amino-cephalosporanic acid 3 are contracted by thiadiazoles
It closes chaining and forms TDA.The quality of TDA is most important to the purity and yield of Cefazolin sodium.Synthesis TDA common method master at present
There are Aqueous phase and catalysis method, Aqueous phase takes water as a solvent, and alkali used is often sodium bicarbonate, ammonium hydroxide, triethylamine etc., this method cost
Low, reaction condition is mild, and pollution is small, small to actual bodily harm;Catalysis method common solvent is acetonitrile, ether, tetrahydrofuran etc., yield
5-7% high compared with Aqueous phase, but that there are toxicity is big for used catalyst boron trifluoride, and by-product is difficult to recycle, and is unfavorable for environmental protection.
A kind of synthetic method of Cefazolin sodium Intermediate TDA is disclosed in patent CN201210112682.6, with acetone,
Second is cured, ether, dimethyl carbonate, methylene chloride or chloroform are that solvent, 7-ACA and thiadiazoles are packed into according to the weight ratio of 1:1.2
In reaction vessel, it is passed through boron triflouride gas into reaction vessel, controls the temperature in reaction vessel between 0-50 DEG C, reaction
It remains to 7-ACA less than 1% within 1-8 hours, crystallization is hydrolyzed to reactant using sodium carbonate, sodium bicarbonate or ammonium hydroxide, then
Finished product TDA is obtained by suction filtration, washing and drying process.It is disclosed in patent CN20111024214.5 and a kind of prepares cephalo azoles
The method of woods sodium compound uses dimethyl carbonate for solvent, and boron trifluoride is catalyst, the weight of 7-ACA and thiadiazoles 1:0.5
Amount ratio is reacted, and is carried out crystallization to reactant with ammonium hydroxide after reaction, using filter, washing, drying, is obtained TDA.It is above-mentioned
Boron trifluoride catalyst is all made of in scheme, boron trifluoride is toxic and price is high, also needs to handle containing boride after reaction
Waste, higher cost are not suitable for large-scale production.
A kind of synthetic method of Cefazolin Intermediate TDA is disclosed in patent CN201010014470.4, using cephalo
Rhzomorph C is oxidized to GL-7-ACA through D-AAO, then reacts with 2- methyl-5-sulfydryl-1,3,4-thiadiazole, uses
GL-7-ACA ACY sloughs glutaryl and obtains TDA.The technical solution uses biological enzyme reaction synthesis, environmentally protective nothing
Pollution, solves the problems, such as that consumption of organic solvent is big in chemical production, but it needs first to synthesize GL-7-ACA, then synthesizes GL-
TDA finally just synthesizes TDA, and synthesis step is more, and whole yield is lower, is unfavorable for industrialized production.
Therefore, seeking one kind, there is high yield, high quality, the simple synthetic method of reaction process to seem most important.
Summary of the invention
In view of the deficiencies of the prior art, the object of the present invention is to provide a kind of synthetic method of Cefazolin Intermediate TDA,
Simple process, solvent are mild, reduce the use of organic solvent, the high income of the TDA of preparation is with high purity, and color is good.
The synthetic method of Cefazolin Intermediate TDA of the present invention, using phosphate buffer and acetone as solvent, with
7-ACA and thiadiazoles are raw material, react under the action of catalyst, obtain TDA;
The catalyst is triethylamine or ammonium hydroxide, preferably triethylamine.
Wherein, the mass ratio of 7-ACA and thiadiazoles is 1:0.5-1.
The mass ratio of 7-ACA and catalyst is 1:0.8-1.0.
Preferably, the synthetic method of the Cefazolin Intermediate TDA, comprising the following steps:
(1) it prepares phosphate buffer: buffer substance being dissolved in purified water, is shaken up, phosphate-buffered is made in constant volume
Liquid, pH value 7.6-8.0.
(2) it synthesizes TDA: phosphate buffer and acetone being mixed, thiadiazoles and catalyst is sequentially added, is warming up to 60-
70 DEG C, 7-ACA is added, reacts 1.5-3h, adds Sodium Metabisulfite and EDTA, the reaction was continued to 7-ACA residual quantity <
1.0%, reaction terminates, and is down to room temperature, and it is 3.8-4.0 that dilute hydrochloric acid, which is added, and adjusts pH value, under the conditions of 20-25 DEG C, crystallization 30-
50min, then it is cooled to 0-5 DEG C, it filters, washes 2-3 times, acetone is washed 2-3 times, is dried in vacuo to get TDA product.
Buffer substance is one of potassium dihydrogen phosphate, sodium dihydrogen phosphate and disodium hydrogen phosphate, phosphoric acid hydrogen two in step (1)
The mixture of one of potassium, sodium hydroxide.
The mixed volume ratio of phosphate buffer and acetone is 4-9:1 in step (2).
Sodium Metabisulfite in step (2), EDTA, 7-ACA mass ratio be 0.03-0.05:0.02-0.05:1.
The concentration of dilute hydrochloric acid is 15-20% in step (2).
Compared with prior art, the invention has the following beneficial effects:
(1) present invention can keep the stabilization of reacting liquid pH value, using phosphate buffer as solvent to solve to react
The problem of adding lye repeatedly because of pH reduction in the process;
(2) a small amount of acetone is added in a solvent, it is miscellaneous can to remove in the reaction part during synthesizing TDA by the present invention
Matter, to improve product purity;
(3) TDA yield prepared by the present invention can reach 110~115%, and purity is higher than 98%, and color is good, technique letter used
List, solvent are mild, meet the energy-saving and emission-reduction requirement of country's promotion, mitigate environmental protection pressure, are suitable for industrialized production.
Specific embodiment
The present invention will be further described with reference to embodiments, but protection scope of the present invention is not limited only to this, the neck
Domain professional changes to made by technical solution of the present invention, is within the scope of protection of the invention interior.
Embodiment 1
(1) phosphate buffer is prepared
Dipotassium hydrogen phosphate 0.59g, potassium dihydrogen phosphate 0.41g are weighed, purified water is added to dissolve and is settled to 1000mL, is shaken up
The phosphate buffer that pH value is 7.8, it is spare.
(2) TDA is synthesized
500mL three-necked flask is taken, the phosphate buffer 1 80mL of Fresh is added, acetone 60mL is added while stirring
Thiadiazoles 12g, is slowly added dropwise triethylamine 8g in 35 DEG C, is warming up to 60 DEG C wait be added dropwise, and 7- is added after all dissolutions
ACA12g reacts 2h, adds Sodium Metabisulfite 0.6g, EDTA0.6g, and the reaction was continued, sample detection, remains < to 7-ACA
1.0%, reaction terminates, and is cooled to room temperature, in reaction solution be added dropwise 15% dilute hydrochloric acid adjust pH value be 3.8, growing the grain 30min,
Ice water is cooled to 5 DEG C again, filters, and is washed 2 times with 100mL, 200mL acetone is washed 3 times, and TDA dry product is dried in vacuo to obtain in 60 DEG C
13.70g, yield are 1.14 (in terms of 7-ACA), content 98.3%.
Embodiment 2
(1) phosphate buffer is prepared
Disodium hydrogen phosphate 0.48g, potassium dihydrogen phosphate 0.41g are weighed, purified water is added to dissolve and is settled to 1000mL, is shaken up
The phosphate buffer that pH is 8.0, it is spare.
(2) TDA is synthesized
500mL three-necked flask is taken, the phosphate buffer 260mL of Fresh is added, acetone 40mL is added while stirring
Thiadiazoles 8g, is slowly added dropwise triethylamine 10.2g in 35 DEG C, is warming up to 65 DEG C wait be added dropwise, and 7- is added after all dissolutions
ACA12g reacts 2h, adds Sodium Metabisulfite 0.6g, EDTA0.45g, and the reaction was continued, sample detection, remains to 7-ACA
< 1.0%, reaction terminates, and is cooled to room temperature, and the dilute hydrochloric acid adjusting pH value that 18% is added dropwise in reaction solution is 4.0, growing the grain
40min, then ice water are cooled to 5 DEG C, filter, and are washed 2 times with 150mL, 200mL acetone is washed 3 times, is dried in vacuo to obtain TDA in 60 DEG C
Dry product 13.62g, yield are 1.135 (in terms of 7-ACA), content 98.2%.
Embodiment 3
(1) phosphate buffer is prepared
Dipotassium hydrogen phosphate 2.72g is weighed, adds purified water to dissolve and is settled to 100mL.100mL is taken, 0.20mol hydroxide is added
Sodium solution 84.8mL is added water and is diluted to the phosphate buffer that 400mL is 7.6 to get pH, spare.
(2) TDA is synthesized
500mL three-necked flask is taken, the phosphate buffer 270mL of Fresh is added, acetone 30mL is added while stirring
Thiadiazoles 6g, is slowly added dropwise ammonium hydroxide 12g in 35 DEG C, is warming up to 68 DEG C wait be added dropwise, and 7-ACA12g is added after all dissolutions,
2.5h is reacted, Sodium Metabisulfite 0.36g, EDTA0.24g are added.Sample detection remains < 1.0%, reaction knot to 7-ACA
Beam is cooled to room temperature, and it is 3.9 that certain 20% salt acid for adjusting pH value is added dropwise in reaction solution, and growing the grain 50min, then ice water are cooled to 0
DEG C, filter, with 120mL wash 2 times, 200mL acetone is washed 3 times, be dried in vacuo in 60 DEG C TDA dry product 13.35g, yield are
1.11 (in terms of 7-ACA), content 98.0%.
Claims (10)
1. a kind of synthetic method of Cefazolin Intermediate TDA, it is characterised in that: using phosphate buffer and acetone as solvent,
Using 7-ACA and thiadiazoles as raw material, reacts under the action of catalyst, obtain TDA;
The catalyst is ammonium hydroxide or triethylamine.
2. the synthetic method of Cefazolin Intermediate TDA according to claim 1, it is characterised in that: 7-ACA and thiadiazoles
Mass ratio be 1:0.5-1.
3. the synthetic method of Cefazolin Intermediate TDA according to claim 1, it is characterised in that: 7-ACA and catalyst
Mass ratio be 1:0.8-1.0.
4. the synthetic method of Cefazolin Intermediate TDA according to claim 1, it is characterised in that: the following steps are included:
(1) it prepares phosphate buffer: buffer substance being dissolved in purified water, is shaken up, phosphate buffer is made;
(2) it synthesizes TDA: phosphate buffer and acetone being mixed, thiadiazoles and catalyst is sequentially added, is warming up to 60-70 DEG C,
7-ACA is added, reacts 1.5-3h, adds Sodium Metabisulfite and EDTA, the reaction was continued to 7-ACA residual quantity < 1.0%, instead
It should terminate, be down to room temperature, it is 3.8-4.0 that dilute hydrochloric acid, which is added, and adjusts pH value, crystallization, then is cooled to 0~5 DEG C, filters, washs, does
It is dry to get TDA product.
5. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: buffering in step (1)
Substance is one of potassium dihydrogen phosphate, sodium dihydrogen phosphate and one of disodium hydrogen phosphate, dipotassium hydrogen phosphate, sodium hydroxide
Mixture.
6. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: phosphoric acid in step (1)
The pH value of salt buffer is 7.6-8.0.
7. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: phosphoric acid in step (2)
The mixed volume ratio of salt buffer and acetone is 4-9:1.
8. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: laid particular stress in step (2)
Sodium sulfite, EDTA, 7-ACA mass ratio be 0.03-0.05:0.02-0.05:1.
9. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: dilute salt in step (2)
The concentration of acid is 15-20%.
10. the synthetic method of Cefazolin Intermediate TDA according to claim 4, it is characterised in that: analysis in step (2)
Brilliant temperature is 20-25 DEG C, and the crystallization time is 30-50min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811581537.6A CN109336905A (en) | 2018-12-24 | 2018-12-24 | The synthetic method of Cefazolin Intermediate TDA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811581537.6A CN109336905A (en) | 2018-12-24 | 2018-12-24 | The synthetic method of Cefazolin Intermediate TDA |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109336905A true CN109336905A (en) | 2019-02-15 |
Family
ID=65297198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811581537.6A Pending CN109336905A (en) | 2018-12-24 | 2018-12-24 | The synthetic method of Cefazolin Intermediate TDA |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109336905A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6374488A (en) * | 1986-09-18 | 1988-04-04 | Asahi Chem Ind Co Ltd | Production of 7-aminocephalosporanic acid and derivative thereof |
CN1594321A (en) * | 2004-06-23 | 2005-03-16 | 哈药集团制药总厂 | Process for preparing cephazoline three-position intermediate |
-
2018
- 2018-12-24 CN CN201811581537.6A patent/CN109336905A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6374488A (en) * | 1986-09-18 | 1988-04-04 | Asahi Chem Ind Co Ltd | Production of 7-aminocephalosporanic acid and derivative thereof |
CN1594321A (en) * | 2004-06-23 | 2005-03-16 | 哈药集团制药总厂 | Process for preparing cephazoline three-position intermediate |
Non-Patent Citations (2)
Title |
---|
KAZUO KARIYONE ET AL.: "CEFAZOLIN, A NEW SEMISYNTHETIC CEPHALOSPORIN ANTIBIOTIC. I SYNTHESIS AND CHEMICAL PROPERTIES OF CEFAZOLIN", 《THE JOURNAL OF ANTIBIOTIC》 * |
张秋荣等: "头孢替唑钠的合成工艺", 《中国药物化学杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101613361B (en) | Method for preparing cefoxitin sodium | |
CN107033161B (en) | A kind of synthetic method of tazobactam | |
CN103539803A (en) | Method for preparing ceftriaxone sodium | |
CN105399754B (en) | A kind of preparation method of Cefamandole Nafate | |
CN113754647A (en) | Synthesis method of sulfuryl pyraflufen-ethyl and intermediate thereof | |
CN109678744A (en) | A kind of method that serialization prepares glycine | |
CN109336905A (en) | The synthetic method of Cefazolin Intermediate TDA | |
CN107266473B (en) | A kind of synthetic method of cefotaxime | |
CN109651401A (en) | The preparation method of Cefuroxime Sodium | |
CN113880902A (en) | Molnupiravir drug intermediate and preparation method thereof | |
CN101735250A (en) | Ceftezole sodium compound with novel route | |
CN111533710B (en) | Method for preparing cefotiam intermediate 2-aminothiazole-4-acetic acid by one-pot method | |
CN117417333A (en) | Synthesis process of pyribenzoxim sulfone | |
CN101525340B (en) | Method for synthesizing 7-phenylacetylamino-3-chloromethyl cephalosporin alkyl acid p-methoxybenzyl ester | |
CN110357903B (en) | Synthetic method of tazobactam acid | |
CN107892676A (en) | The preparation method of Cefdinir active thioester | |
CN113699209A (en) | 7-ADCA recovery method | |
CN105732457A (en) | Method for preparing succinimide with succinic acid fermentation liquor | |
CN109912625A (en) | A kind of process reducing cefotaxime impurity H | |
CN105294734A (en) | Method for preparing cefonicid dibenzyl ethylenediamine salt | |
CN107235857B (en) | A kind of preparation method of cyclohexanone oxime | |
CN104356155B (en) | Preparation method of (S)-tert-butyldimethylsilyloxy-glutaramate | |
CN115784978B (en) | Method for synthesizing 2-amino-6-bromopyridine | |
CN110241167A (en) | A kind of method that enzyme process prepares Mandokef sodio-derivative | |
CN112724089B (en) | Synthesis process of 2-amino-3-bromo-6-chloropyrazine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190215 |